https://www.pro.novartis.com/ar-es/ 2026-03-30T06:39:29+00:00 daily 1.0 https://www.pro.novartis.com/ar-es/node/6 2025-02-17T18:30:14+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/node/51 2025-03-04T01:00:26+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/node/161 2025-03-04T01:01:32+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/node/311 2025-03-04T01:00:42+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/node/331 2025-03-18T17:25:11+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/node/346 2025-03-04T01:00:02+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/node/366 2025-03-04T01:00:11+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/node/401 2025-03-04T01:07:44+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/proximamente 2026-03-30T05:47:21+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/hematologia 2026-03-30T06:34:08+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/todo-lo-que-necesitas-saber-sobre-la-enfermedad-injerto-contra-huesped 2026-03-30T06:15:50+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/hematologia/foco-en-neoplasias-mieloproliferativas-cronicas 2026-03-30T06:29:19+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/hematologia/ciclo-de-entrevistas-hematologia-expertos 2026-03-30T06:29:19+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/solicitud-de-informacion-medica 2026-03-30T06:02:12+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/informacion-medica/estudios-iniciados-por-investigadores-iits 2026-03-30T06:01:35+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/hematologia/el-desafio-de-la-enfermedad-de-injerto-vs-huesped-resistente-o-refractaria-esteroides 2026-03-30T06:29:19+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/conversando-sobre-eich-con-el-dr-daniel-couriel 2026-03-30T06:29:11+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/neurologia 2025-06-30T01:39:04+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/jakavi-ruxolitinib/mecanismo-de-accion 2026-03-30T08:33:22+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/jakavi-ruxolitinib/dosis-y-administracion 2026-03-30T08:34:48+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/demo-video-card 2025-03-04T00:58:24+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/neurologia/esclerosis-multiple-recurrente 2025-04-25T20:52:00+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/neurologia/ventana-de-oportunidad 2025-03-04T18:21:40+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/objetivo-terapeutico 2025-03-04T18:24:12+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/desiciones-compartidas 2025-04-25T20:53:01+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/conversacion-entre-expertos 2025-04-25T20:54:47+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/neurologia/riesgos-y-beneficios-de-uso-de-ofatumumab 2025-03-12T20:53:00+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/estudio-concert-estudio-multicentrico-de-cohorte-retrospectivo 2025-10-14T01:20:20+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/estudio-panorama 2025-03-12T20:58:51+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/neurologia/expertos-en-esclerosis-multiple 2025-03-12T21:07:11+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/scemblix-asciminib/mecanismo-de-accion 2026-03-30T08:15:39+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/decisiones-compartidas 2025-02-22T21:12:28+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/scemblix-asciminib/perfil-de-seguridad 2026-03-30T08:15:49+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/kesimpta-ofatumumab/mecanismo-de-accion 2026-03-30T06:40:30+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/scemblix-asciminib/dosis-y-administracion 2026-03-30T08:15:49+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/scemblix-asciminib/lanzamiento-3ra-linea 2026-03-30T08:15:49+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/scemblix-asciminib/el-correcto-monitoreo-importa 2026-03-30T08:33:14+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/congreso-actrims-2024 2025-04-16T18:10:46+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/congreso-ectrims-2024 2025-08-27T20:38:41+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/kesimpta-ofatumumab/perfil-de-seguridad 2026-03-30T06:00:59+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/programa-de-soporte-a-pacientes 2026-03-30T08:36:12+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/kesimpta-ofatumumab/dosis-y-administracion 2026-03-30T06:00:59+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/kesimpta-ofatumumab/kesimpta-en-un-minuto 2026-03-30T06:00:59+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/cardiometabolismo 2026-03-30T08:36:04+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/cardiometabolismo/el-rol-del-c-ldl-en-la-ecva 2026-03-30T08:33:30+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/cardiometabolismo/seguridad-y-eficacia-de-inclisir%C3%A1n 2026-03-30T08:33:30+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/cardiometabolismo/congreso-acc-2024 2026-03-30T08:31:47+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/cardiometabolismo/congreso-scc-2024 2026-03-30T08:31:47+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/cardiometabolismo/dislipidemias-diagnostico-clinico-del-colesterol-alto 2026-03-30T08:34:24+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/cardiometabolismo/tipos-de-colesterol-y-sus-funciones-en-el-metabolismo-lipidico 2026-03-30T08:33:41+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/servicio-de-originales-sin-cargo 2026-03-30T06:33:59+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/cardiometabolismo/perfil-lipidico-recomendaciones-para-optimizar-el-control-de-los-valores-de-cldl 2026-03-30T08:34:08+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/cardiometabolismo/incidencia-del-colesterol-alto-en-la-diabetes 2026-03-30T08:34:08+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/cardiometabolismo/evaluacion-de-los-niveles-de-colesterol-ldl-en-sangre-como-marcador-de-riesgo-cardiovascular 2026-03-30T08:34:08+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/cardiometabolismo/definicion-clinico-medica-de-las-dislipidemias-secundarias 2026-03-30T08:34:33+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/video-cards-example 2025-03-04T01:02:58+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/cardiometabolismo/lipoproteina-en-la-identificacion-y-manejo-de-las-dislipidemias 2026-03-30T08:36:04+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/cardiometabolismo/manejo-integral-de-factores-de-riesgo-cardiovascular 2026-03-30T08:35:15+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/endocrinologia-proximamente 2026-03-30T06:27:26+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/terapia-genica-proximamente 2026-03-30T06:13:54+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/hematologia/congreso-esh-2025 2026-03-31T03:00:00+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/oncologia/post-gigu-simposio-novartis 2025-04-16T17:56:46+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/empeza-ahora 2025-04-16T17:56:56+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/psp-programa-de-soporte-pacientes-de-novartis 2026-03-30T08:28:11+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/oncologia/post-texas-simposio 2025-04-16T17:56:51+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/nuevas-herramientas-para-el-diagnostico-del-cancer-de-mama-en-los-hospitales-de-cipolletti-allen-y 2025-06-06T18:32:51+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/oncologia/cancer-de-mama/cancer-y-mujer-2025 2026-03-30T08:32:58+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/on-the-go 2026-03-30T05:19:45+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/cursos-de-capacitacion-profesional-2025-sal-novartis 2025-05-19T20:08:40+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/oncologia/cancer-de-mama/reconocer-la-necesidad-insatisfecha 2025-10-20T03:04:07+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/rescue-therapy-workshop 2026-03-30T05:19:38+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/kisqali-ribociclib/mecanismo-de-accion 2026-03-30T08:31:12+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/kisqali-ribociclib/dosis-y-administracion 2026-03-30T08:31:12+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/kisqali-ribociclib/perfiles-de-pacientes 2026-03-30T08:35:15+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/kisqali-ribociclib/estudio-right-choice 2026-03-30T08:31:12+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/kisqali-ribociclib/estudio-monaleesa 2026-03-30T08:31:21+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/kisqali-ribociclib/estudio-ribanna 2026-03-30T08:31:21+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/terapia-genica 2026-03-30T08:34:48+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/terapia-genica/que-es-la-terapia-de-reemplazo-genico-grt-y-como-funciona 2026-03-30T08:26:55+00:00 hourly 0.5 https://www.pro.novartis.com/ar-espinal 2026-03-30T08:26:55+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/inmunoai-challenge-2025 2025-05-27T21:01:08+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/terapia-genica/lactante-hipotonico-marco-diagnostico-de-su-fisiopatologia 2026-03-30T08:27:06+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/terapia-genica/signos-de-alarma-al-examen-fisico-del-lactante-hipotonico 2026-03-30T08:28:19+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/terapia-genica/elementos-clave-para-la-evaluacion-clinica-del-lactante-hipotonico 2026-03-30T08:28:19+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/terapia-genica/conceptos-etiologicos-basicos-del-lactante-hipotonico-con-ame 2026-03-30T08:28:19+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/terapia-genica/clasificacion-clinica-del-lactante-hipotonico-con-ame-claves-medicas 2026-03-30T08:27:14+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/terapia-genica/lactante-hipotonico-con-ame-elementos-del-diagnostico-diferencial 2026-03-30T08:27:14+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/terapia-genica/claves-del-diagnostico-diferencial-del-lactante-hipotonico-con-ame 2026-03-30T08:27:14+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/terapia-genica/lactante-hipotonico-con-ame-pruebas-geneticas-y-electrodiagnosticas 2026-03-30T08:28:19+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/sybravar-inclisiran/sybravar-mecanismo-de-accion 2025-07-08T14:56:48+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/sybravar-inclisiran/sybravar-perfil-de-seguridad 2025-08-07T21:44:18+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/sybravar-inclisiran/sybravar-dosis-y-administracion 2025-08-07T21:53:47+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/zolgensma/indicaciones-para-zolgensma 2026-03-30T08:34:40+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/zolgensma/compra-centralizada-de-zolgensmar-por-el-ministerio-de-salud 2026-03-30T08:27:47+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/espacio-zolgensmar 2026-03-30T08:34:48+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/oncologia/international-medical-summit-de-cancer-de-mama-munich-alemania-2025 2025-09-26T20:39:06+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/kisqali-ribociclib/nccn-esmo-mcbs-scorecards 2026-03-30T08:31:21+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/cosentyx-secukinumab/mecanismo-de-accion-cosentyx 2026-03-30T08:30:27+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/cosentyx-secukinumab/perfil-de-seguridad-cosentyxr 2026-03-30T08:35:06+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/cosentyx-secukinumab/dosis-y-administracion 2026-03-30T08:35:15+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/cosentyx-secukinumab/rescue-therapy-workshop 2026-03-30T08:30:37+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/cosentyx-secukinumab/uso-de-biologicos-en-psoriasis 2026-03-30T08:34:40+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/cosentyx-secukinumab/guias-de-tratamiento-grappa 2026-03-30T08:30:37+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/cosentyx-secukinumab/cosentyxr-en-psoriasis 2026-03-30T08:30:46+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/cosentyx-secukinumab/cosentyxr-en-artritis-psoriasica 2026-03-30T08:30:46+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/cosentyx-secukinumab/cosentyxr-en-espondiloartritis-axial 2026-03-30T08:30:46+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/cosentyx-secukinumab/cosentyxr-en-artritis-idiopatica-juvenil-are-apsj 2026-03-30T08:30:46+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/cosentyx-secukinumab/cosentyxr-en-hidradenitis-supurativa 2026-03-30T08:30:46+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/hematologia/eha-2025 2025-11-02T20:11:27+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/perspectivas-actuales-sobre-el-cancer-de-mama-temprano-rh-her2-tratamiento-adyuvante-en-pacientes 2025-06-13T13:45:35+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/pluvictor-en-argentina-un-nuevo-horizonte-en-la-terapia-oncologica-con-radioligandos 2025-06-30T23:59:26+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/hematologia/descubri-los-avances-mas-recientes-en-lmc-hpn-y-pv 2025-07-24T12:49:06+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/oncologia/actualizacion-en-cancer-de-mama-post-asco-2025 2025-10-13T17:37:43+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/eular-2025 2025-08-04T14:01:27+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/mecanismo-de-accion 2026-03-30T06:39:14+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/necesidad-insatisfecha-en-cprcm 2026-03-30T06:39:14+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/dosis-y-administracion-pluvicto-vieja 2026-03-30T06:40:00+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/calidad-de-vida 2026-03-30T06:32:54+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/eficacia 2026-03-30T06:32:54+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/kisqali-ribociclib/kisqalir-esta-aprobado-para-cancer-de-mama-temprano-rhher2 2025-08-13T16:18:14+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/revivi-el-lanzamiento-de-pluvictor 2026-03-25T00:26:09+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/grappa-2025 2025-07-10T17:59:03+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/scemblix-asciminib/descubriendo-scemblixr-pensar-fuera-de-la-caja 2025-11-27T13:58:27+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/hematologia/hay-necesidades-insatisfechas-en-la-hemoglobinuria-paroxistica-nocturna-hoy 2025-07-25T14:19:51+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/capsulas-irep 2025-08-22T16:26:32+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/oncologia/nova-talks-actualizaciones-en-cancer-de-mama-rh-her2 2025-09-26T20:43:17+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/hematologia/estudio-asc4first-96-semanas-contado-por-expertos 2025-08-12T19:13:15+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/fabhaltar-iptacopan/descubriendo-fabhaltar 2025-08-19T16:33:57+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/esmo-bc-2025-guias-eventos-adversos-kisqali 2025-08-13T16:26:17+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/simposio-kisqali-agosto-2025 2025-08-08T18:16:25+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/prueba 2025-08-01T15:02:00+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/simposio-pluvicto-agosto-2025 2025-08-19T15:30:24+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/dermatologia 2025-10-09T17:52:50+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/dermatologia/sintesis-de-los-puntos-clave-del-nuevo-concenso-de-la-hs-sad 2025-08-21T19:28:08+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/dermatologia/epidemiologia-e-impacto-de-la-psoriasis 2025-08-21T20:16:58+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/dermatologia/hs-entendiendo-la-carga-de-la-enfermedad 2025-08-21T20:12:42+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/dermatologia/cuales-son-las-necesidades-no-cubiertas-de-la-hs 2025-08-21T20:13:07+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/dermatologia/hs-ventana-de-oportunidad-terapeutica 2025-08-21T19:36:40+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/dermatologia/diagnostico-y-manejo-de-la-hs 2025-08-21T19:37:04+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/dermatologia/todo-lo-que-neceitas-saber-sobre-hidradenits-supurativa 2025-08-21T20:11:31+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/dermatologia/resultados-primarios-del-estudio-sunny-semana-104 2025-08-21T21:54:46+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/dermatologia/congreso-eadv-2024 2025-08-21T20:14:55+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/dermatologia/congreso-aad-2024 2025-08-21T20:15:18+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/reumatologia 2025-08-21T20:11:37+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/reumatologia/la-artritis-psoriasica 2025-08-21T20:11:59+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/reumatologia/estudio-maximise 2025-08-21T20:12:25+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/simposio-novartis-riesgo-cardio-renal-metabolico 2025-09-03T14:01:19+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/reumatologia/estudio-exceed 2025-08-21T20:12:47+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/estudio-prevent 2025-08-21T20:13:41+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/estudio-surpass 2025-08-21T20:14:01+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/reumatologia/evidencia-existente-en-el-manejo-de-espaax 2025-08-21T20:14:28+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/reumatologia/conversaciones-sobre-espaax 2025-08-21T21:56:07+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/reumatologia/estudios-measure-1-2-y-3 2025-08-21T20:15:15+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/reumatologia/la-espondiloartritis-axial 2025-08-21T20:15:45+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/reumatologia/highlights-eular-2024 2025-08-21T20:15:49+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/reumatologia/congreso-acr-2024 2025-08-21T20:15:52+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/fabhaltar-iptacopan/mecanismo-de-accion-fabhalta 2026-03-30T06:20:23+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/fabhaltar-iptacopan/dosis-y-administracion-fabhalta 2026-03-30T06:20:23+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/fabhaltar-iptacopan/perfil-de-seguridad-fabhalta 2026-03-30T06:20:23+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/congreso-eas-latam-2025 2025-09-04T14:13:30+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/fabhaltar-iptacopan/estudio-apply-pnh 2026-03-30T06:20:37+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/welcome-cosentyx 2025-09-02T19:40:48+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/fabhaltar-iptacopan/estudio-appoint-pnh 2026-03-30T06:20:37+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/transformando-el-abordaje-del-cprcm-pluvictor-simposio 2026-03-25T00:26:12+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/preguntas-mas-frecuentes 2025-08-27T01:55:03+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/en-el-cmt-rh-her2-kisqalir-ia-evito-mas-de-1-de-cada-4-recurrencias-vs-ia-sola6 2025-10-23T15:59:15+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/simposios-ebc-kisqali 2025-09-24T17:44:14+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/simposio-sau-2025-radioligandos 2025-09-22T18:06:27+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/solicitud-contacto-radioligandos 2025-11-03T16:02:58+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/endocrinologia 2026-03-30T06:37:32+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/lactancia-materna-durante-tratamiento-con-ofatumumab 2025-08-28T14:54:33+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/que-es-la-acromegalia 2026-03-30T06:37:04+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/causas-de-la-acromegalia 2026-03-30T06:36:56+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/sintomas-de-la-acromegalia 2026-03-30T06:37:04+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/diagnostico-de-la-acromegalia 2026-03-30T06:36:56+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/tratamiento-de-la-acromegalia 2026-03-30T06:37:04+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/manejo-de-la-acromegalia 2026-03-30T06:36:56+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/endocrinologia/acromegalia-guia-de-tratamiento 2026-03-30T06:36:01+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/hipervinculo 2026-03-30T06:24:35+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/congreso-cardiometabolismo-sac-2025 2025-09-24T17:00:25+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/simposio-novartis-congreso-argentino-de-pediatria-2025 2025-10-13T14:14:23+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/cosentyx-10 2025-12-02T20:29:59+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/ame-go-2025 2025-09-08T13:08:51+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/mayzent-mecanismo-de-accion 2025-09-11T17:23:12+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/mayzent-perfil-de-seguridad 2025-09-11T16:58:57+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/mayzent-dosis-y-administracion 2025-09-16T14:54:50+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/avant-premiere-kisqali 2025-09-24T17:31:32+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/congreso-ectrims-2025 2025-09-27T16:53:57+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/congreso-esc-2025 2026-01-30T18:51:49+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/oncologia/cancer-de-prostata/el-futuro-de-la-oncologia-de-precision-en-cancer-de-prostata 2026-01-13T20:28:41+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/oncologia/cancer-de-prostata/psma-y-su-valor-como-target-diagnostico-y-terapeutico-para-el-cprcm 2025-11-12T20:21:52+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/oncologia/cancer-de-prostata/comprender-el-cancer-de-prostata-y-la-carga-de-la-enfermedad 2025-11-12T20:34:46+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/webinar-conarec 2025-10-17T20:18:27+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/actualidad-tecnologia-e-innovacion/realidad-virtual-y-aumentada 2026-03-30T06:31:48+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/pluvictor-lutecio-177lu-vipivotida-tetraxetan/pluvictor-nueva-indicacion-prequimioterapia 2026-01-30T17:26:17+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/estudio-vision 2026-03-12T21:57:01+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/actualidad-tecnologia-e-innovacion/health-tech-la-promesa-para-el-sector-salud 2026-03-30T06:32:28+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/actualidad-tecnologia-e-innovacion/avances-y-aplicaciones-de-la-ia 2026-03-30T06:32:12+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/actualidad-tecnologia-e-innovacion/medicina-personalizada 2026-03-30T06:32:37+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/actualidad-tecnologia-e-innovacion/medicina-de-precision 2026-03-30T06:32:54+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/actualidad-tecnologia-e-innovacion/ciberseguridad-en-la-salud 2026-03-30T06:33:09+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/actualidad-tecnologia-e-innovacion/tecnologia-en-la-medicina-de-precision 2026-03-30T06:32:04+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/actualidad-tecnologia-e-innovacion/nanotecnologia-para-mejorar-tratamientos 2026-03-30T06:32:28+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/actualidad-tecnologia-e-innovacion/ia-y-tecnologias-utilizadas-en-el-sector-de-la-salud 2026-03-30T06:32:28+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/congreso-nefrologia-argentina-renal 2025-11-19T15:15:37+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/pluvictor-lutecio-177lu-vipivotida-tetraxetan/estudio-psmafore 2025-10-22T23:29:06+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/perfiles-de-pacientes-pluvicto 2026-03-31T19:43:24+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/perfil-de-seguridad-pluvicto 2026-03-12T21:57:41+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/latam-summit 2025-10-20T19:58:10+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/programa-de-deteccion-temprana-de-ame-2025 2025-10-16T13:12:15+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/clone-actualizacion-en-cancer-de-mama-post-asco-2025 2025-10-13T19:43:56+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/clone-congreso-nefrologia-argentina-renal-test 2025-10-30T14:07:26+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/oncologia/esmo-2025 2026-03-28T00:01:03+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/congreso-sani-2025 2025-11-17T13:29:08+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/congreso-sac-2025 2026-01-26T22:16:51+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/kisqali-ribociclib/lanzamiento-kisqali-en-adyuvancia 2025-10-28T00:57:44+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/estudio-psmaaddition-esmo-2025 2025-11-03T12:52:41+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/iii-jornadas-hospitales-publicos-live-streaming 2025-10-31T01:18:32+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/kisqali-ribociclib/esmo-2025-actualizacion-natalee-5-anos 2025-10-24T15:46:54+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/simposio-urotarget-2025 2025-11-08T21:49:11+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/simposio-promo-pluvicto 2026-03-19T14:08:33+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/simposio-jornadas-celso-papadopulos-2025 2025-11-08T21:48:09+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/solicitud-info-urologos 2025-10-28T18:06:56+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/hematologia/esh-icmlf-2025 2025-11-18T15:20:01+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/can-2025 2025-12-01T12:32:52+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/simposio-congreso-sah-2025-fabhalta 2025-11-05T16:22:51+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/registro-contenido-lpa 2025-11-07T00:26:23+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/oncologia/cancer-de-mama/hospitales-publicos 2025-12-04T12:24:03+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/presentacionescongresotx2025 2025-11-13T20:51:58+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/fabhaltar-iptacopan/conversando-sobre-fabhaltar-con-los-expertos-internacionales 2025-11-27T14:21:00+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/pedido-articulo-lpa 2025-11-19T18:41:45+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/congreso-sat-presentacion 2025-11-18T14:10:50+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/cure-sma-2025 2025-11-20T17:23:28+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/innovacion-en-la-ciencia-y-tecnologia-en-la-ultima-decada 2026-01-05T17:17:44+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/endocrinologia/acromegalia 2026-03-30T06:38:17+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/endocrinologia/acromegalia-diagnostico-tratamiento-y-avances-tecnologicos 2026-03-30T06:38:17+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/endocrinologia/acromegalia-y-comorbilidades 2026-03-30T06:38:00+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/nkf-scm-0 2025-12-01T02:13:32+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/wcn 2025-12-01T12:32:30+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/era 2025-12-01T12:48:03+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/endocrinologia/calidad-de-vida-en-la-acromegalia 2026-03-30T06:38:09+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/endocrinologia/acromegalia-y-embarazo 2026-03-30T06:38:09+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/endocrinologia/acromegalia-y-enfermedad-cardiovascular 2026-03-30T06:38:09+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/nefrologia 2026-03-25T20:10:09+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/diagnostico-de-nefropatia-por-iga 2026-02-02T19:20:27+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/diagnostico-de-glomerulopatia-por-c3 2026-03-12T14:22:27+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/renal-jose-duca 2025-12-11T19:49:19+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/investigacion-clinica-iptacopan 2025-12-11T23:28:16+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/proceso-de-calidad-iptacopan 2025-12-11T19:48:14+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/test-pdf 2026-01-07T15:58:47+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/highlights-aha 2025-12-17T15:31:46+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/pluvictor-lutecio-177lu-vipivotida-tetraxetan/dosis-y-administracion-pluvicto 2026-03-12T21:48:01+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/mas-sobre-inclisiran 2025-12-19T14:06:18+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/psmafore-webinar-series 2026-01-29T01:24:00+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/vision-webinar-series 2026-01-28T03:42:12+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/oncologia/cancer-de-prostata/consenso-sparc 2026-01-14T12:49:22+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/hipercolesterolemia-familiar-en-cardiologia 2026-01-29T12:47:55+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/medicacion-hipolipemiante-luego-de-un-sindrome-coronario-agudo 2026-02-06T14:47:09+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/recorrido-de-una-doisis 2026-03-12T22:02:40+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/introduccion-la-enfermedad-cronica-renal 2026-03-12T14:19:28+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/guias-para-tratamiento-de-colesterol-elevado 2026-01-27T22:39:18+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/transitando-un-camino-sinuoso-cambios-hormonales-y-metabolismo-lipidico-en-la-mujer-una-mirada-de 2026-03-14T18:17:41+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/colesterol-ldl-c-ldl-es-el-verdadero-factor-de-riesgo-de-aterosclerosis 2026-02-10T23:57:37+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/novedades-en-el-tratamiento-de-nefropatia-por-iga 2026-03-12T14:17:30+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/perfiles-de-paciente 2026-02-11T17:39:02+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/dislipemia-y-prevencion-secundaria-del-accidente-cerebrovascular 2026-02-10T16:19:54+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/actividad-fisica-y-deportes-en-prevencion-cardiovascular-primaria-y-secundaria 2026-02-10T16:19:20+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/adherencia-terapeutica-en-los-tratamientos-cronicos 2026-02-10T18:23:11+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/hidradenitis-supurativa-de-las-guias-la-practica 2026-03-18T11:52:27+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/rol-del-complemento-en-la-patogenesis-de-nefropatia 2026-03-30T05:20:10+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/productos/pluvictor-lutecio-177lu-vipivotida-tetraxetan/pluvictor-en-lineas-tempranas-que-nos-dicen 2026-03-04T19:04:04+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/evaluacion-y-pronostico-de-la-progresion-de-la-enfermedad-renal-cronica-erc 2026-02-26T19:45:49+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/asco-gu-2026 2026-04-02T23:02:50+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/nefrologia/contacto-nefrologia 2026-03-09T13:58:51+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/nefrologia/estudio-de-la-eficacia-y-seguridad-de-iptacopan-en-pacientes-con-nefropatia-primaria-por 2026-03-30T06:40:30+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/nefrologia/investigacion-clinica-el-futuro-de-la-nefrologia-clinica 2026-03-12T23:19:27+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/cuidado-integral-e-innovacion-en-salud-publica-y-adultos-mayores 2026-03-19T14:37:22+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/hidradenitis-supurativa-de-las-guias-la-practica-modulo-1 2026-03-30T17:25:45+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/iptacopan-fabhaltar-para-nefropatia-por-iga 2026-03-31T19:21:05+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/hidradenitis-supurativa-de-las-guias-la-practica-modulo-2 2026-03-30T17:31:16+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/hidradenitis-supurativa-de-las-guias-la-practica-modulo-3 2026-03-31T16:58:47+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/node/16 2025-03-04T01:01:35+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/node/106 2025-03-04T01:00:15+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/node/116 2025-03-04T01:00:39+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/node/251 2025-03-04T01:01:38+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/node/256 2025-03-04T01:01:42+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/node/261 2025-03-04T01:01:45+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/node/271 2025-03-04T01:00:47+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/node/296 2025-03-18T17:25:44+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/node/306 2025-03-04T00:58:48+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/hematologia/hemato-forum-actualizaciones-en-pv-hpn-lmc 2025-06-04T12:55:59+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/actualizaciones-en-cancer-de-mama-post-asco-2025 2025-06-14T15:55:14+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/foros-virtuales-instituto-alexander-fleming 2025-09-16T08:09:40+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/foro-virtual-iaf-foco-en-pacientes-anosas 2025-09-25T11:51:16+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/productos/webinar-evento-lanzamiento-pluvictor 2026-02-20T17:41:32+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/foros-virtuales-instituto-angel-roffo 2025-11-30T02:51:44+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/inmunoai-challenge 2025-10-21T18:51:04+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/nova-talks-actualizaciones-en-cancer-de-mama-rh-her2 2025-06-30T23:59:36+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/rescue-therapy-workshop-2025 2025-09-01T17:51:07+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/cosentyx-10-anos-live 2025-12-01T17:21:30+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/clone-cosentyx-10-anos-live-prueba-form 2025-09-18T12:44:26+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/cosentyx-10-anos-live-stream 2025-11-20T17:28:28+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/lanzamiento-renal 2025-09-24T22:38:51+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/simposio-novartis-ribociclib-redefiniendo-la-adyuvancia-en-cancer-de-mama-rh-her2 2025-09-26T16:28:17+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/jornada-hospitales-publicos 2025-10-31T16:13:46+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/evento-de-sybravar-la-urgencia-de-lograr-los-objetivos-terapeuticos-de-c-ldl 2026-03-03T16:12:00+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/node/1 2025-03-04T01:07:25+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/node/36 2025-03-04T01:00:32+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/node/41 2025-03-04T01:00:08+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/node/46 2025-03-04T01:00:05+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/node/66 2025-03-04T00:59:58+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/node/71 2025-10-14T02:49:27+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/node/76 2025-03-04T01:00:28+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/node/81 2024-12-02T07:15:00+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/node/86 2026-02-02T19:22:02+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/node/91 2024-10-02T17:05:12+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/node/96 2024-06-27T05:06:38+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/node/111 2024-09-09T13:33:00+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/node/276 2025-03-04T01:01:20+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/node/281 2025-03-04T01:01:24+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/node/291 2025-03-04T00:58:44+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/pagina-no-encontrada 2025-02-28T21:07:10+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/node/341 2025-03-04T01:08:29+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/acceso-denegado 2025-02-03T00:23:52+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/node/391 2024-12-18T08:07:47+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/node/396 2025-03-04T00:59:35+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/non-logged-user-homepage 2026-03-30T06:39:29+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/logged-user-homepage 2026-03-30T06:38:56+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/productos 2026-03-30T06:37:42+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/terminos-y-condiciones 2026-03-30T05:49:19+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/aviso-de-privacidad 2026-03-30T05:49:07+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/hematologia/congreso-eha-2024 2026-03-30T06:29:19+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/informacion-medica 2026-03-30T06:34:08+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/oncologia 2025-11-03T15:21:16+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/oncologia/cancer-de-prostata 2025-11-03T15:23:31+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/oncologia/cancer-de-mama 2025-11-03T15:24:17+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/prueba-productos 2025-08-07T20:47:19+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/productos/pluvictor-lutecio-177lu-vipivotida-tetraxetan/centros-de-infusion-de-pluvictor 2025-11-27T15:05:19+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/demo-poi2 2025-08-12T18:03:45+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/actualidad-tecnologia-e-innovacion 2026-03-30T06:33:49+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/congresos-internacionales-nefrologia-2025 2025-12-01T02:08:44+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/node/56 2025-09-03T04:07:39+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/node/266 2025-09-03T04:07:39+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/productos/cosentyx-secukinumab 2026-03-30T06:39:05+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/productos/jakavi-ruxolitinib 2026-03-30T06:33:49+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/productos/mayzent-siponimod 2026-03-30T06:29:11+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/productos/gilenya-fingolimod 2026-03-30T06:26:44+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/productos/piqray-alpelisib 2026-03-30T06:26:44+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/productos/ilaris-canakinumab 2026-03-30T06:31:24+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/productos/luxturnar-voretigen-neparvovec 2026-03-30T06:26:52+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/productos/kesimpta-ofatumumab 2026-03-30T06:26:52+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/productos/scemblix-asciminib 2026-03-30T08:32:50+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/productos/kisqali-ribociclib 2026-03-30T08:32:58+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/productos/sybravar-inclisiran 2026-02-05T23:00:47+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/productos/zolgensma 2026-03-30T08:34:40+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/pluvictor-lutecio-177lu-vipivotida-tetraxetan-vieja 2026-03-30T06:39:21+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/certicanr-everolimus 2025-09-03T04:07:39+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/lucentisr-ranibizumab 2025-09-03T04:07:39+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/vsiqqr-brolucizumab 2025-09-03T04:07:39+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/sandimmun-neoralr-ciclosporina 2025-09-03T04:07:39+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/myforticr-micofenolato-sodico 2025-09-03T04:07:39+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/simulectr-basiliximab 2025-09-03T04:07:39+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/revolader-eltrombopag 2025-09-03T04:07:39+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/rydaptr-midostaurina 2025-09-03T04:07:39+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/tasignar-nilotinib 2025-09-03T04:07:39+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/tafinlarr-dabrafenib 2025-09-03T04:07:39+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/mekinistr-trametinib 2025-09-03T04:07:39+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/afinitorr-everolimus 2025-09-03T04:07:39+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/aimovigr-erenumab 2025-09-03T04:07:39+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/onbrizer-breezhalerr-indacaterol 2025-09-03T04:07:39+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/seebrir-breezhalerr-glicopirronio 2025-09-03T04:07:39+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/glivecr-imatinib 2025-09-03T04:07:39+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/jadenur-deferasirox 2025-09-03T04:07:39+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/sandostatinr-larr-octreotida 2025-09-03T04:07:39+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/zometar-acido-zoledronico 2025-09-03T04:07:39+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/ritalinar-metilfenidato 2025-09-03T04:07:39+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/productos/fabhaltar-iptacopan 2026-03-30T06:34:24+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/sandimmunr-ciclosporina 2025-09-03T04:07:39+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/productos/pluvictor-lutecio-177lu-vipivotida-tetraxetan 2026-03-12T21:51:44+00:00 daily 0.5 https://www.pro.novartis.com/ar-es/webshop/kesimptar-ofatumumab-20mg04ml 2026-03-30T06:32:45+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/webshop/kisqali-ribociclib-200mg 2026-03-30T06:32:37+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/webshop/mayzent-sinonimod-2mg 2026-03-30T06:32:37+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/webshop/sybrava-inclisiran-284-mg 2026-03-30T06:32:45+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/webshop/kisqalir-ribociclib-200mg 2025-10-06T05:28:31+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/webshop/mayzentr-siponimod-2-mg 2025-10-06T05:28:31+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/webshop/mayzentr-siponimod-025mg 2025-10-06T05:28:31+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/webshop/scemblixr-asciminib-40mg 2025-10-06T05:28:31+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/webshop/tasignar-nilotinib-150-mg-x-120-capsulas-duras 2025-10-06T05:28:31+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/webshop/tasignar-nilotinib-200-mg-x-120-capsulas-duras 2025-10-06T05:28:31+00:00 hourly 0.5 https://www.pro.novartis.com/ar-es/sitemap.xml 2026-04-02T00:50:47+00:00